US Stock MarketDetailed Quotes
BLUE bluebird bio
- 0.406
- +0.024+6.18%
Close Nov 8 16:00 ET
- 0.418
- +0.012+3.03%
Post 19:49 ET
78.67MMarket Cap-176P/E (TTM)
0.419High0.380Low5.98MVolume0.380Open0.382Pre Close2.43MTurnover3.10%Turnover RatioLossP/E (Static)193.91MShares5.53052wk High1.49P/B78.31MFloat Cap0.33752wk Low--Dividend TTM193.02MShs Float152.883Historical High--Div YieldTTM10.21%Amplitude0.337Historical Low0.406Avg Price1Lot Size
About bluebird bio Company
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
Company Profile
SymbolBLUE
Company Namebluebird bio
Listing DateJun 19, 2013
Issue Price17.00
Founded1992
CEOMr. Andrew Obenshain
MarketNASDAQ
Employees375
Fiscal Year Ends12-31
Address455 Grand Union Boulevard
CitySomerville
ProvinceMassachusetts
CountryUnited States of America
Zip Code02145
Phone1-339-499-9300
Websitehttp://www.bluebirdbio.com
Company Executives
-
Name
- Position
- Salary
-
Andrew Obenshain
- Director, President and Chief Executive Officer
- 3.05M
-
O. James Sterling
- Chief Financial Officer and Principal Accounting Officer
- --
-
Richard A. Colvin
- Chief Medical Officer
- 1.34M
-
Joseph Vittiglio
- Chief Legal and Business Officer
- --
-
O. James Sterling
- Chief Financial Officer and Principal Accounting Officer
- --
-
Thomas J. Klima
- Chief Commercial and Operating Officer
- 1.33M
-
Mark Vachon
- Chairman of the Board
- 200.91K
-
Michael Cloonan
- Director
- --
-
Nick Leschly
- Director
- 96.41K
-
Najoh Tita-Reid
- Independent Director
- 153.91K
-
Dr. John O. Agwunobi, M.D.
- Independent Director
- 160.91K
-
Richard Paulson, M.B.A.
- Independent Director
- 65.24K
-
Dr. Charlotte Jones-Burton, M.D.,M.S.
- Independent Director
- 146.41K
-
Dr. Elisabeth Leiderman, M.D.
- Independent Director
- 167.91K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
